Table 4:

Initial posttreatment versus subsequent follow-up

Combined Primary and NodesPosttreatmentFollow-Up
NI-RADS 15.7% (5/88)3.4% (15/440)
NI-RADS 220.0% (4/20)15.8% (6/38)
NI-RADS 350.0% (4/8)62.5% (15/24)
Combined, all categories11.2% (13/116)7.2% (36/502)